Results 111 to 120 of about 15,072 (244)

Eplerenone tetrahydrofuran solvate

open access: yesActa Crystallographica Section E Structure Reports Online, 2007
The eplerenone mol­ecule of the title compound, C24H30O6·C4H8O, contains three six-membered rings, two five-membered rings and one three-membered ring. In the crystal structure, the eplerenone mol­ecules are linked via C—H⋯O hydrogen bonds, forming a 303 A3 cavity, which is occupied by two disordered solvent THF mol­ecules.
Qian Yang   +3 more
openaire   +1 more source

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome [PDF]

open access: yes, 2019
When hypertension, a pathology that is frequently found in the general population, presents in a young patient, secondary causes such as Cushing's syndrome (CS), a rare disease characterized by long-term elevated cortisol levels, should be considered ...
Barbot, Mattia   +2 more
core   +1 more source

Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy

open access: yesFrontiers in Pharmacology
BackgroundThe renin-angiotensin-aldosterone system (RAAS) members, especially Ang II and aldosterone, play key roles in the pathogenesis of diabetic cardiomyopathy (DCM).
Lin Xie   +6 more
doaj   +1 more source

Remote results of using aldosterone antagonists in complex treatment of patients with myocardial infarction and heart failure [PDF]

open access: yes, 2015
The work presents remote results of using aldosterone in complex treatment of patients with myocardial infarction combined with heart failure. It is shown that after using of eplerenone the authenticity of renewal functional indexes of myocardium becomes
Gulaga, O.I.   +3 more
core  

Тривале спостереження за хворими на гострий інфаркт міокарда при використанні антагоністів альдостерону [PDF]

open access: yes, 2013
Проведено аналіз віддалених результатів використання антагоністів альдостерону (спіронолактону та еплеренону) у комплексному лікуванні хворих на інфаркт міокарда з серцевою недостатністю.
Гулага, Ольга Ігорівна   +2 more
core  

Missed opportunities: low use of evidence-based treatment with eplerenone after myocardial infarction - a nationwide study [PDF]

open access: bronze, 2013
Siv Mari Berger   +7 more
openalex   +1 more source

EPLERENONE TREATMENT FOR SYMPTOMATIC SUBFOVEAL SEROUS PIGMENT EPITHELIAL DETACHMENT

open access: bronze, 2022
Jayant Kumar   +36 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy